Skip to main navigation

About
Pipeline
Clinical Trials
Partners
News
Investors
Contact
Community

PRESS RELEASES

Webcast

Q2 2022 TRACON Pharmaceuticals, Inc. Earnings Conference Call

08/10/22 4:30 PM EDT

Keyword Search

Year:

08/08/22

Summary Toggle
TRACON Pharmaceuticals Announces Submission of IND Application for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab

Printer Friendly

PDF Version
07/27/22

Summary Toggle
TRACON to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 10, 2022

Printer Friendly

PDF Version
07/26/22

Summary Toggle
TRACON Pharmaceuticals Announces Dosing of 36th Patient in ENVASARC Pivotal Trial Triggering Initial IDMC Efficacy Review Expected in the Fourth Quarter

Printer Friendly

PDF Version
06/02/22

Summary Toggle
TRACON Pharmaceuticals to Present at the Jefferies Healthcare Conference

Printer Friendly

PDF Version
05/16/22

Summary Toggle
TRACON Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

Printer Friendly

PDF Version
05/11/22

Summary Toggle
TRACON Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Printer Friendly

PDF Version
05/04/22

Summary Toggle
TRACON to Report First Quarter 2022 Financial Results and Corporate Update on May 11, 2022

Printer Friendly

PDF Version
04/19/22

Summary Toggle
TRACON Pharmaceuticals Announces Amended ENVASARC Protocol Approved and Open at all 30 Clinical Sites in the U.S. and U.K.

Printer Friendly

PDF Version
03/23/22

Summary Toggle
TRACON Pharmaceuticals to Present at the Maxim Group 2022 Virtual Growth Conference

Printer Friendly

PDF Version
03/15/22

Summary Toggle
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

Printer Friendly

PDF Version

Pagination

Current page 1
Page 2
Page 3
Page 4
…
Next page
Last page

Print Page
RSS Feeds
Email Alerts
Contact

4350 La Jolla Village Drive
Suite 800
San Diego, CA 92122

Phone: (858) 550-0780
Fax: (858) 550-0786
Email: info@traconpharma.com

About

Management
Board of Directors
Scientific Advisory Board

News

Press Releases
Publications

Pipeline

Envafolimab (KN035)
TRC102
TRC253

Partners

Contact

Clinical Trials

Investors

Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
- Historical Price Lookup
- Investment Calculator
Investor FAQ
Contact

Copyright © TRACON Pharmaceuticals, Inc. 2022